Skip to content
healthcare.dev

Risedronate Sodium

NDC 60505-3096, Risedronate Sodium, tablet, film coated, from Apotex Corp..

Product NDC
60505-3096
Status
Listed
Labeler
Apotex Corp.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA090877
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/60505-3096 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RISEDRONATE SODIUM75 mg/1

Pharmacologic classes

Bisphosphonate [EPC]; Diphosphonates [CS]

Package NDCNDC-11Package
60505-3096-2605053096021 BLISTER PACK in 1 CARTON (60505-3096-2) / 2 TABLET, FILM COATED in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/b90f2e5b-10b8-29a7-0360-31bd0dae0ec2

Use it

Look up 60505-3096 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/60505-3096 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 60505-3096. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.